(CRSP) Crispr Therapeutics - Performance -32.2% in 12m
Compare CRSP with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-59.74%
#73 in Group
Rel. Strength
19.82%
#6380 in Universe
Total Return 12m
-32.18%
#81 in Group
Total Return 5y
-41.03%
#46 in Group
P/E -
(?) Percentile in Group
P/E Forward 23.4
72th Percentile in Group
PEG -0.21
39th Percentile in Group
FCF Yield -8.47%
(?) Percentile in Group
12m Total Return: CRSP (-32.2%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CRSP vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRSP
| Total Return (including Dividends) | CRSP | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.57% | 11.81% | 13.81% |
| 3 Months | -8.30% | -13.61% | -6.30% |
| 12 Months | -32.18% | -12.29% | 10.65% |
| 5 Years | -41.03% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | CRSP | XBI | S&P 500 |
| 1 Month | -35.5% | 72.9% | 83% |
| 3 Months | -77.0% | -83% | -75.3% |
| 12 Months | -85.6% | -51.6% | 50.1% |
| 5 Years | -77.7% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #73 | 3.37% | 1.55% |
| 3 Month | #67 | 6.15% | -2.13% |
| 12 Month | #81 | -22.7% | -38.7% |
| 5 Years | #49 | -21.5% | -71.6% |
FAQs
Does CRSP Crispr Therapeutics outperforms the market?
No,
over the last 12 months CRSP made -32.18%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CRSP made -8.30%, while XBI made -13.61%.
Over the last 3 months CRSP made -8.30%, while XBI made -13.61%.
Performance Comparison CRSP vs Indeces and Sectors
CRSP vs. Indices CRSP is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.39% | 1.76% | -25.1% | -42.8% |
| US NASDAQ 100 | QQQ | -5.58% | -1.79% | -25.3% | -43.8% |
| US Dow Jones Industrial 30 | DIA | -5.80% | 5.58% | -24.8% | -39.9% |
| German DAX 40 | DAX | -5.37% | 0.61% | -51.3% | -57.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.57% | 3.74% | -25.8% | -39.6% |
| Hongkong Hang Seng | HSI | -8.56% | -4.36% | -33.4% | -45.9% |
| India NIFTY 50 | INDA | -0.47% | 10.7% | -25.5% | -32.0% |
| Brasil Bovespa | EWZ | -6.44% | -1.67% | -33.8% | -23.9% |
CRSP vs. Sectors CRSP is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.03% | 2.16% | -32.1% | -53.7% |
| Consumer Discretionary | XLY | -5.77% | 1.34% | -24.1% | -46.5% |
| Consumer Staples | XLP | -4.53% | 8.98% | -32.0% | -41.3% |
| Energy | XLE | -5.21% | 8.81% | -18.5% | -22.7% |
| Financial | XLF | -6.49% | 2.05% | -32.2% | -54.6% |
| Health Care | XLV | -2.38% | 14.7% | -20.1% | -28.1% |
| Industrial | XLI | -7.08% | -1.25% | -26.5% | -43.2% |
| Materials | XLB | -5.19% | 2.01% | -20.2% | -27.0% |
| Real Estate | XLRE | -4.07% | 4.03% | -25.8% | -47.6% |
| Technology | XLK | -6.47% | -5.65% | -22.2% | -39.3% |
| Utilities | XLU | -5.44% | 5.98% | -32.7% | -49.7% |
| Aerospace & Defense | XAR | -7.37% | -5.59% | -36.6% | -59.5% |
| Biotech | XBI | 1.20% | 3.76% | -4.91% | -19.9% |
| Homebuilder | XHB | -5.86% | 4.09% | -11.9% | -24.6% |
| Retail | XRT | -7.29% | 0.92% | -20.8% | -30.7% |